SBIR PHASE I. TOPIC321:CHEMICALLY DEFINED GLYCAN LIBRARIES FOR REFERENCE STANDARD
SBIR PHASE I. TOPIC321:CHEMICALLY DEFINED GLYCAN LIBRARIES FOR REFERENCE STANDARD
批准号:
8758478
负责人:
HAI YU
金额:
$29.84万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2013
资助国家:
美国
项目状态:
已结题
起止时间:
2013-09-12 至 2014-06-11
关键词:
2-cyclopentyl-5-(5-isoquinolylsulfonyl)-6-nitro-1H-benzo(D)imidazoleBiological AssayCancer VaccinesCarbohydratesCell membraneComplexDataDiagnosticEventGlycosphingolipidsHeadHealthHumanLibrariesMalignant NeoplasmsMass Spectrum AnalysisNMR SpectroscopyNational Institute of General Medical SciencesPhasePolysaccharidesProductionReference StandardsResolutionSeriesSialic AcidsSmall Business Innovation Research GrantStructureTestingTherapeuticValidationbasecostcost effectivedesignmolecular recognitionnovelscreening
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Glycosphingolipids are essential components of human plasma membrane. More than 300
glycosphingolipid glycans have been characterized. The glycans are directly involved in molecular
recognition event. A number of cancer-associated glycosphingolipid glycans are being developed as
cancer vaccines. Most glycosphingolipid glycans are not commercially available. The costs for a limited
number of commercially available ones are extremely high. We have developed highly effective one-pot
multienzyme (OPME) approaches for high-yield and cost-effective production of complex glycans. The
OPME approaches will be used in generating a library of 60 structurally diverse glycosphingolipid glycans
including those contain different naturally occurring sialic acid forms. Three specific aims are to
synthesize 1) ganglio-series; 2) lacto- and neolacto-series; and 3) globo- and isoglobo-series
glycosphingolipid glycans using our established high efficient OPME strategies. Each of the 60
compounds will be synthesized under GLP conditions in 10-50 mg scale, purified to >98% purity, and
characterized by nuclear magnetic resonance spectroscopy (NMR) and high-resolution mass
spectrometry (HRMS). For all glycans synthesized (>98% purityL 50 micrograms of each will be sent to
an NIGMS-designed screening center for validation testing, glycan microarray and other screening
assays. These glycans are essential standards and invaluable probes for bioassays and biomedical
applications.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
海外基金